Thirty Inspiring Middle School Scientists and Engineers Shine as Finalists in the Thermo Fisher Scientific Junior Innovators Challenge
WASHINGTON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Society for Science today announced the 30 finalists in the Thermo Fisher Scientific Junior Innovators Challenge (Thermo Fisher JIC), the nation's pre...
Thermo Fisher Scientific Launches Efficient-Pro Medium (+) Insulin for Enhanced Bioprocessing Performance
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ Efficient-Pro™ Medium (+) Insulin, a next-generation medium designed t...
Thermo Fisher Scientific Inc. (TMO) J.P. Morgan CEO Call Series Call (Transcript)
Thermo Fisher Scientific Inc. J.P. Morgan CEO Call Series September 5, 2025 1:00 PM EDT Company Participants Marc Casper - Chairman, President & CEO Conference Call Participants Rachel Vatnsdal Ols...
Thermo Fisher: Growth Acceleration And Margin Expansion Should Drive The Upside
Revenue growth is accelerating, led by pharma/biotech momentum and bioproduction demand. The medium-term margin outlook is positive with cost cuts, AI-driven efficiencies, and lapping of tariff hea...
Investing in Thermo Fisher (TMO)? Don't Miss Assessing Its International Revenue Trends
Explore how Thermo Fisher's (TMO) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Thermo Fisher Scientific Stock Jumps on Strong Results, Higher Outlook
Thermo Fisher Scientific (TMO) shares took off after the maker of lab equipment and other life sciences products posted better-than-expected results and boosted its guidance, citing operational imp...
Thermo Fisher shares surge after Q2 beat, boosted by product launches
Shares of Thermo Fisher Scientific Inc (NYSE:TMO, ETR:TN8) jumped nearly 12% on Wednesday morning after the company reported second-quarter results that topped Wall Street estimates, fueled by stro...
Thermo Fisher Scientific (TMO) Tops Q2 Earnings and Revenue Estimates
Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.36 per share, beating the Zacks Consensus Estimate of $5.22 per share. This compares to earnings of $5.37 per share a year ago.
Thermo Fisher Scientific Company Analysis Report | Key Milestones/History, Product Offerings, Technologies, Major Applications and End-user Industries
Discover an in-depth analysis of Thermo Fisher Scientific in this comprehensive report, covering milestones, product offerings, and technologies. Explore their financial performance, strategic alli...
TMO to Report Q2 Earnings: Analytical Instruments Segment in Focus
Thermo Fisher eyes second-quarter 2025 growth with new tech launches in Analytical Instruments and Life-Science Solutions segments.
Thermo Fisher Scientific: Recovery In Sight, Attractively Valued
Thermo Fisher has good growth prospects ahead. Core pharma, biotech, and bioproduction businesses are driving growth, with US manufacturing investments and the Solventum acquisition strengthening f...
TMO Launches Next-Generation Mass Spectrometers: Stock to Gain?
Thermo Fisher debuts two advanced MSs, Orbitrap Astral Zoom and Orbitrap Excedion Pro, to accelerate precision medicine and drug discovery breakthroughs.
Thermo Fisher: With A 30% Price Drop, Trump Legislation, And High Capex, Is It Undervalued?
The neutral DCF model implemented in this article suggests that Thermo Fisher is undervalued by 29.24%. Thermo Fisher has invested, on average, 16.51% of its revenues in capex between 2019 and 2024...
Thermo Fisher Is Strengthening Its Long-Term Advantage
Thermo Fisher's 2025 headwinds from tariffs and US research funding cuts are real but temporary, not reflective of structural weakness in its fundamentals. The company is mitigating trade impacts b...
Thermo Fisher Launches New Spectral Flow Cytometer: Stock to Gain?
TMO unveils spectral-enabled Attune Xenith Flow Cytometer to streamline workflows and boost research accuracy.
Related Companies